Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Nov;30(6):1092-1099.
doi: 10.1002/jcla.21986. Epub 2016 May 17.

SNCA Gene Polymorphism may Contribute to an Increased Risk of Alzheimer's Disease

Quanbao Wang  1 , Qian Tian  1 , Xiaojie Song  1 , Yunyong Liu  1 , Wei Li  2
Affiliations

SNCA Gene Polymorphism may Contribute to an Increased Risk of Alzheimer's Disease

Quanbao Wang et al. J Clin Lab Anal. 2016 Nov.

Abstract

Background: The purpose of this study is to elucidate the association between α-synuclein (SNCA) polymorphisms and the risk of Alzheimer's disease (AD).

Methods: The PCR-RFLP was applied to detect SNCA gene rs6532190, rs3775430, and rs10516846 polymorphisms in 98 AD patients and 105 healthy elderly.

Results: The GG frequency of rs10516846 was evidently increased in AD group than control group (P < 0.05). There was a significant difference in SNCA level between the AD and control groups (P < 0.01). In the AD group, the SNCA level in cerebrospinal fluid of GG (rs10516846) carriers was increased as compared with AA carriers (P < 0.05). The GG (rs10516846) frequency of the early-onset AD group is significantly higher than that of the late-onset AD group (P < 0.05). The frequency of rs3775430 GG was lower in the early-onset group than that in the late-onset group (0% vs. 16.7%). The SNCA level in cerebrospinal fluid of GG (rs10516846) carriers in the early-onset AD group is higher than that of AA carriers (P < 0.05).

Conclusion: SNCA gene polymorphism may be associated with an increased risk of AD and GG genotype of rs10516846 and elevated SNCA level in CSF may increase the risk of early-onset AD.

Keywords: SNCA; Alzheimer's disease; Polymorphism; Risk; rs10516846.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Comparison of SNCA level in CSF between the AD group and control group. Note: AD, Alzheimer's disease; CSF, cerebral spinal fluid.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Liu S, Zeng F, Wang C, et al. The nitric oxide synthase 3 G894T polymorphism associated with Alzheimer's disease risk: a meta‐analysis. Sci Rep 2015;5:13598. - PMC - PubMed
    1. Joshi YB, Giannopoulos PF, Pratico D. The 12/15‐lipoxygenase as an emerging therapeutic target for Alzheimer's disease. Trends Pharmacol Sci 2015;36:181–186. - PMC - PubMed
    1. van der Flier WM, Pijnenburg YA, Fox NC, et al. Early‐onset versus late‐onset Alzheimer's disease: the case of the missing APOE varepsilon4 allele. Lancet Neurol 2011;10:280–288. - PubMed
    1. Paz YMC, Garcia‐Cardenas JM, Lopez‐Cortes A, et al. Positive association of the Cathepsin D Ala224Val gene polymorphism with the risk of Alzheimer's disease in Ecuadorian population. Am J Med Sci 2015;350:219–231. - PubMed
    1. Al‐Asmary SM, Kadasah S, Arfin M, et al. Apolipoprotein E polymorphism is associated with susceptibility to schizophrenia among Saudis. Arch Med Sci 2015;11:869–876. - PMC - PubMed